FedEx Corporation vs Halozyme Therapeutics Inc. Common Stock — how do they compare? FedEx Corporation trades at $291.15 (market cap $69.04B), while Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B). The key difference: FedEx Corporation is far larger — about 5.5× Halozyme Therapeutics Inc. Common Stock's market cap, and FedEx Corporation pays a 1.67% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Halozyme Therapeutics Inc. Common Stock for 0 Days on average.
| FDX | HALO | |
|---|---|---|
Market Cap | $69.04B | $12.58B |
Volume | 1,287,367 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $339.35 | $115.22 |
52-Week Low | $180.87 | $61.63 |
Typical Hold Time | 87 Days | 0 Days |
Enterprise Value | $98.68B | $14.49B |
Dividend Yield | 1.67% | — |
Signals from Pluang's Aura AI — not financial advice
FDX trades at $290.98, up 0.67% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $6.31 exceeding the $5.96 estimate. Revenue for 2025 was $87.93 billion, with a net income margin of 4.68%. Recent news includes a $300 million order for electric trucks from Harbinger and shareholder approval of executive compensation.
The outlook is mixed: analyst consensus is bullish with a $307.55 price target, but rising fuel costs and geopolitical tensions pose near-term risks. Earnings growth and cost-cutting initiatives support upside, while margin pressure from higher diesel prices and competitive pressures are key concerns for investors.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →